Bioventus Inc.
BVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $686,229 | $330,153 | $160,226 | $658,896 |
| - Cash | $41,582 | $36,964 | $30,186 | $43,933 |
| + Debt | $356,055 | $394,846 | $418,066 | $357,682 |
| Enterprise Value | $1,000,702 | $688,035 | $548,106 | $972,645 |
| Revenue | $573,280 | $512,345 | $512,117 | $430,898 |
| % Growth | 11.9% | 0% | 18.8% | – |
| Gross Profit | $388,226 | $328,193 | $331,080 | $302,706 |
| % Margin | 67.7% | 64.1% | 64.6% | 70.3% |
| EBITDA | $39,221 | -$23,070 | -$121,606 | $45,475 |
| % Margin | 6.8% | -4.5% | -23.7% | 10.6% |
| Net Income | -$33,542 | -$156,230 | -$158,704 | $19,375 |
| % Margin | -5.9% | -30.5% | -31% | 4.5% |
| EPS Diluted | -0.52 | -2.49 | -2.59 | -0.15 |
| % Growth | 79.1% | 3.9% | -1,626.7% | – |
| Operating Cash Flow | $38,795 | $15,344 | -$13,537 | $22,991 |
| Capital Expenditures | -$1,006 | -$7,362 | -$1,478 | -$20,890 |
| Free Cash Flow | $37,789 | $7,982 | -$15,015 | $2,101 |